The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence. (Q38046893)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 October 2012
edit
Language Label Description Also known as
English
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence.
scientific article published on 10 October 2012

    Statements

    The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit